Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 9—September 2020
Research

Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France

Alexandre J. VivantiComments to Author , Jérémie Mattern, Christelle Vauloup-Fellous, Jacques Jani, Luc Rigonnot, Larissa El Hachem, Agnès Le Gouez, Céline Desconclois, Imane Ben M’Barek, Jeanne Sibiude, Alexandra Benachi, Olivier Picone, and Anne-Gaël Cordier
Author affiliations: Antoine Béclère Hospital, Paris Saclay University, Clamart, France (A.J. Vivanti, J. Mattern, A. Le Gouez, C. Desconclois, A. Benachi); Paul Brousse Hospital, Paris Saclay University, Villejuif, France (C. Vauloup-Fellous); University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium (J. Jani); Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, France (L. Rigonnot, L. El Hachem); Bicêtre Hospital, Paris Saclay University, Le Kremlin-Bicêtre, France (I. Ben M’Barek, A.-G. Cordier); Louis Mourier Hospital, Paris University, Colombes, France (J. Sibiude, O. Picone)

Main Article

Table 5

Maternal outcomes of 10 pregnant women admitted to the intensive unit with severe acute respiratory syndrome coronavirus 2, France*

ID
 Age, y
 BMI, kg/m2
 Underlying conditions
Time, h
 Intubation, d
 ICU stay, d
 Drug regimens
 Complications
GA, wk, d
 From O2 >5 L/min to intubation
 From intubation to delivery
At diagnosis
 At intubation
1 30.9† 35.8 NA 28, 5 29, 0 15.5 0 10 12 Lopinavir NA
2 26.5† 29.9 NA 38, 1 POD 2 7 NA 15 16 Hydroxy Surgical site infection
3 24.9† 25.7 Asthma 28, 5 30, 1 10 0 11 13 Lopinavir Iatrogenic pancreatitis
4 32.6† 41.8 Hyper-tension 26, 0 26, 1 10.5 7 36 38 Lopinavir Refractory hypoxemia
5 33.6 30.8 NA 26, 6 27, 6 5.5 0 2 3 NA NA
6 39.4 31.3 Hashimoto thyroiditis 40, 5 POD 8 25 NA 4 5 NA NA
7 33.1† 30.5 NA 23, 5 23, 5 1 Ongoing pregnancy 13 14 Hydroxy Iatrogenic transient hepatitis
8 33.4 29.7 NA 28, 2 NA NA NA NA 3 NA NA
9 26.1 33.7 Asthma 36, 0 POD 1 24 NA 1 2 NA NA
10 42.1† 29.3 NA 26, 6 27, 2 160 0 13 14 NA NA

*BMI, body mass index; GA, gestational age; Hydroxy, hydroxychloroquine; ID, patient identification; NA, not applicable; POD, postoperative day.
†Patients who experienced acute respiratory distress syndrome before intubation.

Main Article

Page created: July 02, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external